GSA Capital Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

GSA Capital Partners’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,669	Closed	-$318K	–	2058
2023 Q4	$318K	Sell	1,669 -976	-37%	-$184K	0.03%	1090
2023 Q3	$527K	Buy	2,645 +460	+21%	+$109K	0.05%	760
2023 Q2	$624K	Buy	+2,185	New	+$607K	0.06%	599
2023 Q1	–	Sell	-1,979	Closed	-$407K	–	2019
2022 Q4	$407K	Buy	+1,979	New	+$500K	0.05%	731
2020 Q4	–	Sell	-21,504	Closed	-$1.63M	–	1684
2020 Q3	$1.63M	Buy	+21,504	New	+$1.22M	0.27%	30
2019 Q4	–	Sell	-12,589	Closed	-$377K	–	1799
2019 Q3	$377K	Buy	+12,589	New	+$535K	0.05%	732

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GSA Capital Partners's SWAV Position: Q1 2024 in Review

GSA Capital Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,669 shares — an estimated $318K sold.

GSA Capital Partners first reported a position in SWAV in Q3 2019 and held it in 6 quarters. The position peaked at $1.63M in Q3 2020. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

GSA Capital Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
GSA Capital Partners sold 1,669 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $318K.
GSA Capital Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
GSA Capital Partners's Shockwave Medical, Inc. Common Stock position peaked at $1.63M in Q3 2020.
488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.